✦ LIBER ✦

0161 Letrozole vs. tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Update of the BIG 1-98 primary core analysis

✍ Scribed by B. Thürlimann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S4 Letrozole vs. Tamoxifen as adjuvant e

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Interpreting breast international group

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB

P181 Cost-effectiveness analysis of letr

✍ J. Karnon; M. Berli`ere; H. Depypere; L. Dirix; G. Jerusalem; P. Neven; R. Parid 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Design, conduct, and analyses of Breast

✍ Giobbie-Hurder, A.; Price, K. N; Gelber, R. D 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 194 KB

PCN32 COST-EFFECTIVENESS ANALYSIS OF LET

✍ J Karnon; TE Delea; NL Papo; V Barghout; SK Thomas; SR Johnston 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCN72 COST-EFFECTIVENESS OF LETROZOLE AN

✍ J Karnon; S Kaura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB